In general, tirzepatide tends to produce similar rates of nausea but potentially different patterns of gastrointestinal effects due to its additional GIP receptor activity
Therefore, guidelines have been developed to address appropriate SGLT-2 inhibitor withdrawal for these cases
By examining various studies, and assessed the extent to which GLP-1 can be integrated into GDM treatment protocols, considering critical parameters such as glucose control, maternal and fetal outcomes, adverse events, and overall patient acceptability
The only intervention proven to counteract it is resistance training
Many report that they were prescribed the drug for weight loss and were never warned about the risk of severe complications
Diabetologia 59(3):533541